Reported 3 months ago
In May 2024, Jim Cramer endorsed AMETEK, Inc. (NYSE:AME) for its strong role in electromechanical devices and the semiconductor industry, describing it as a terrific company. Since then, the stock has seen a modest increase of 6.43%. While AME shows growth potential, some analysts believe that other AI stocks could provide better returns with less risk.
Source: YAHOO
Reported 3 months ago
Consumer sentiment decreased significantly in May, nearing historical lows, yet stock markets remained largely unaffected. The S&P 500 climbed 0.7%, closing near its February highs, even as consumer sentiment dropped from 52.2 to 50.8, according to the University of Michigan. President Trump's announcement of new tariffs did not sway markets, which had experienced a rebound due to a temporary agreement between the U.S. and China to reduce reciprocal tariffs.
Source: YAHOO
Reported 3 months ago
In May 2024, Jim Cramer faced a caller's concerns about Hertz Global Holdings, Inc. (NASDAQ:HTZ), suggesting a watch-and-see approach rather than selling or doubling down. His advice did not yield positive results, as HTZ stock decreased by 2.50% over the last year, briefly hitting Cramer’s $8 target but subsequently declining. Cramer later expressed caution about Bill Ackman's involvement with the stock, recommending that investors consider taking profits. While some potential exists for HTZ, the article suggests that there are more promising AI stocks with higher upside potential.
Source: YAHOO
Reported 3 months ago
Source: INVESTORS
Reported 3 months ago
Source: INVESTORS
Reported 3 months ago
In May 2024, Jim Cramer reassured a caller on Mad Money about investing in Adobe Inc. (NASDAQ:ADBE), despite its 20% year-to-date drop, suggesting its stock was the cheapest he had seen. However, since his endorsement, the stock has fallen further by 16.07%. Cramer later acknowledged Adobe's struggles in a rapidly changing AI landscape, implying that other AI stocks might offer better investment opportunities.
Source: YAHOO
Reported 3 months ago
Source: BARRONS
Reported 3 months ago
In May 2024, Jim Cramer touted First Solar, Inc. (NASDAQ:FSLR) as the primary beneficiary of increased tariffs on Chinese solar cells, asserting it as a leading American-made solar company with potential for growth. However, despite Cramer's optimism, FSLR's stock only increased by 3.21% over the last year, raising questions about the accuracy of his bullish stance. While he continues to express hope for solar stocks, some investors are exploring AI stocks as potentially more lucrative alternatives.
Source: YAHOO
Reported 3 months ago
Cava, a Mediterranean-inspired fast-casual chain, has shown strong performance, with a 10.8% increase in same-store sales despite the economic uncertainties affecting the industry. CEO Brett Schulman emphasized that the company has no plans to raise prices, focusing on providing value to customers amid rising costs in the sector, while competitors like Chipotle and Sweetgreen are facing declines in sales and foot traffic.
Source: YAHOO
Reported 3 months ago
Nvidia股价在截至周五的五个交易日内上涨了16%，主要受到其海外业务的乐观情绪推动，特别是与沙特阿拉伯及阿联酋的扩展协议。Nvidia与沙特新兴AI公司Humain达成协议，预计在未来五年供应数十万个AI芯片。此外，特朗普政府宣布允许阿联酋每年进口50万个Nvidia的AI芯片，进一步提振了股价。尽管面临对半导体调查的不确定性，Nvidia对AI芯片的需求依然强劲，预计将继续吸引大企业投资。
Source: YAHOO
Reported 3 months ago
Source: INVESTORS
Reported 3 months ago
Source: WSJ
Reported 3 months ago
Source: BARRONS
Reported 3 months ago
Source: INVESTORS
Reported 3 months ago
As Denmark's Novo Nordisk looks to replace CEO Lars Fruergaard Jorgensen, analysts suggest the company should seek a leader from the U.S., its largest market. With Novo facing increased competition from U.S. rival Eli Lilly in the obesity drug sector, particularly with disparities in sales of their respective medications, having a CEO familiar with the U.S. pharmaceutical landscape could be advantageous. Historically, Novo has had only Danish CEOs, marking a potential shift in company strategy if they choose to appoint an external candidate.
Source: YAHOO
Reported 3 months ago
Source: YAHOO
Reported 3 months ago
Source: INVESTORS
Reported 3 months ago
On May 14, Jim Cramer discussed Bristol-Myers Squibb (NYSE:BMY), emphasizing its struggles due to an impending patent cliff affecting lucrative drugs. While he noted the company's decent oncology portfolio and a 5.6% dividend yield, he advised caution in buying more stock until they see improvements in its new drug COBENFY, which recently had disappointing study results. Cramer is holding off on additional purchases, expecting the stock may drop further.
Source: YAHOO
Reported 3 months ago
In a recent episode of Mad Money, Jim Cramer praised AbbVie Inc. (NYSE:ABBV) as one of his top picks, emphasizing its strong franchises in various medical fields and lack of impending patent cliffs. Despite a recent drop in stock price due to market conditions, he believes AbbVie represents a relatively safe investment, though he suggests evaluating other potential high-return AI stocks.
Source: YAHOO
Reported 3 months ago
Jim Cramer points out that investors are avoiding Johnson & Johnson due to ongoing legal issues linked to past talcum powder claims, despite the company's strong financial position and product pipeline. He emphasizes that the current yield does not sufficiently compensate for the associated risks, leading to a general retreat from the stock.
Source: YAHOO
Reported 3 months ago
Jim Cramer labeled Procter & Gamble (PG) a 'dividend aristocrat' but expressed concerns about its yield not sufficiently compensating for risk. Despite PG's strong consumer product lineup and a long history of increasing dividends, he suggested that promising AI stocks could offer better returns with less risk.
Source: YAHOO
Reported 3 months ago
In a recent episode of Mad Money, Jim Cramer expressed concerns about Colgate-Palmolive's stock, suggesting it 'could go lower.' He pointed out the company's strong product portfolio but noted its significant price drop from highs and lackluster yield. Cramer believes investors might find better opportunities in AI stocks with higher growth potential.
Source: YAHOO
Reported 3 months ago
Source: INVESTORS